Rejection Study
Rejection Study - Related Videos
05:40
A Mouse Aortic Interposition Model to Study Alloimmune-Induced Vascular Rejection
0 Views •
2025
This video demonstrates a method for generating a mouse aortic interposition model to study alloimmune-induced vascular rejection. After placing an anesthetized donor mouse in the supine position, the infrarenal abdominal aorta (IAA) is carefully isolated from surrounding structures. Branching vessels are ligated, and both ends of the IAA are clamped to prevent blood flow before resection. Subsequently, the donor IAA is implanted into an allogeneic recipient mouse, and blood flow is restored...
07:05
Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
0 Views •
Cited by 7 •
2015
We describe a protocol for aortic interposition grafting in mice. The goal of the protocol is to provide a model with which to study pathological processes and therapeutic strategies relevant to alloimmune reactions in arteries and the resultant arterial changes that contribute to organ transplant failure.
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
0 Views •
Cited by 2 •
2007
08:42
A Standardized Murine Model with a Three-Person Workflow for Studying Acute Cellular and Antibody-Mediated Rejection in Xenotransplantation
0 Views •
2026
This study establishes two standardized murine xenotransplantation models to specifically replicate acute cellular rejection and acute antibody-mediated rejection. These models serve as a reliable platform for investigating mechanisms of xenograft immune rejection, evaluating immunosuppressive strategies, and advancing preclinical xenotransplantation research.
FAQs
Mismatched major histocompatibility complex molecules provide important donor antigens that recipient immune cells can recognize as foreign. This recognition promotes T-cell activation, which can coordinate further immune responses against the graft. Examining these mismatches helps researchers connect donor-recipient compatibility with the likelihood of immune-mediated tissue damage and provides a basis for evaluating strategies intended to improve graft survival.
These immune components contribute through related but distinct processes. T-cell responses develop after recipient cells recognize donor antigens, while antibody production adds another pathway for targeting graft-associated foreign material. Inflammation amplifies local tissue injury and can worsen the graft environment. Studying all three responses gives a broader picture of how immune activity contributes to transplant failure.
Immune tolerance aims to reduce harmful responses toward transplanted tissue without eliminating the immune system’s protective functions. Rejection research therefore examines how graft acceptance might be established while preserving defense against infection and abnormal cells. This balance is important because improving transplant outcomes requires controlling donor-directed immunity rather than broadly removing immune protection.
A study can focus on whether recipient immune cells respond to donor antigens, especially differences involving major histocompatibility complex molecules. The observed immune recognition provides information relevant to compatibility testing and anticipated graft damage. Such evaluations help distinguish biological conditions that may support graft survival from those associated with stronger immune activation and greater risk of transplant failure.
Rejection studies provide a framework for examining whether an immunosuppressive treatment reduces the immune processes that damage a graft. Researchers can consider effects on T-cell responses, antibody production, and inflammation, then relate those findings to graft survival. This application supports comparisons among treatment strategies while keeping the central goal of limiting rejection without abandoning immune protection.
Tissue engineering can use findings from rejection research to address how transplanted or engineered tissues interact with recipient immunity. Knowledge of donor-antigen recognition, compatibility, and tolerance can guide efforts to improve acceptance of replacement tissues. The same research context also helps identify approaches that preserve graft function and survival while reducing immune-mediated injury after transplantation.